AR and prostate carcinoma: Therefore, we investigated the in vitro and in vivo effects of SINE on the regulation of AR and ARv in prostate cancer and the molecular mechanisms underlying XPO1 regulated AR and ARv in order to design a novel therapeutic strategy for the treatment of prostate cancer and CRPC.